Please login to the form below

Communiqué Awards 2016: Excellence in Communication of Survey or Market Research Data

The winning programme - Treating beyond symptoms in IBD: The Steroid Assessment Tool. Our approach to medical education is really helping to improve patient outcomes and change lives.


Summary/transcript

Inflammatory bowel disease (IBD) affects more than 250,000 patients in the UK. Treatment strategies have progressed to treating beyond the symptoms of IBD, aiming to reduce mucosal inflammation, sustain remission and prevent bowel damage. 

Steroids have a place in the treatment pathway but do not sustain remission and are associated with significant side effects.The European Crohn’s and Colitis Organisation (ECCO) defines appropriate steroid use and recommends an exit strategy for steroid-dependent patients. However, gastroenterologists are not aware that inappropriate steroid use occurs in their own clinical practice.

Using a simple digital tool, UK experts audited their own practice and were surprised to see high steroid use among their patients. The expert group became advocates for change, motivated to share their data, targeting more than 300 UK HCPs with high steroid use, which comprises approximately 22% of UK IBD clinicians. Awareness of inappropriate steroid use, and the changes driven by the self-realisation of the need to optimise steroids, have the potential to impact the care delivered to over 50,000 UK IBD patients.

13th July 2016

Share

Tags

Company Details

Lucid Group Communications Limited

0345 0536671

Contact Website

Address:
First Floor, Jubilee House
Third Avenue
Globe Park
Marlow
Bucks
SL7 1EY
UK

Latest content on this profile

Climbing my own Lucid Ladder

Lucid Group Communications Limited
A Lucid Thirsty Thursday D&I Special

Lucid Group Communications Limited
Connecting capabilities in healthcare communications

Lucid Group Communications Limited
Connecting capabilities in healthcare communications
The account management/medical writing paradigm was the cornerstone of medcomms for many years, but evolution in technology, storytelling and an increasingly sophisticated audience has changed this.Instead, today's environment requires an integrated, multi-disciplinary approach to cut through the noise, change behaviour, build mental availability for a brand, and advance health outcomes.Connecting multiple capabilities has never been so important. So, how are agencies managing this today?In this webinar, we discuss how our client teams have evolved and how traditional roles have had to change and adapt to help solve today's healthcare challenges.The Lucid Group panel are Jonathan Andrew, Hannah Clarke, Cheryl Harrison Doyle and Madeleine Tye. Please reach out to them on LinkedIn should you have any questions relating to this. As you will hear in this webinar, we are constantly evolving and growing our team's capabilities; both through talent acquisition and internal training opportunities. So, if you're looking for a new career move with a company that offers industry-leading learning development opportunities and growth within your role, please check out all our open roles here:  https://bit.ly/3C9NEva
Lucid Group Communications Limited
Lucid Group: Orange the World

Lucid Group Communications Limited
Connecting capabilities in healthcare communications

Lucid Group Communications Limited